NEXENTIS TECHNOLOGIES INC. Short-Term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) had Short-Term Debt of EUR 1.21 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-03-31
- 2025-12-31: Debt, Current 1.21M EUR.
- 2025-09-30: Debt, Current 1.04M EUR.
- 2025-06-30: Debt, Current 1.04M EUR.
- 2025-03-31: Debt, Current 603.00 EUR.
EUR
| Period end | Debt, Current |
|---|---|
| 2025-12-31 | 1.21M EUR 10-K · filed 2026-03-31 |
| 2025-09-30 | 1.04M EUR 10-Q · filed 2025-11-13 |
| 2025-06-30 | 1.04M EUR 10-Q · filed 2025-08-14 |
| 2025-03-31 | 603.00 EUR 10-Q · filed 2025-05-15 |
USD
| Period end | Debt, Current |
|---|---|
| 2025-12-31 | $1.42M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.22M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.23M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $651.00 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |